£56.56

CRC Press Genetic Toxicology and Cancer Risk Assessment

Price data last checked 42 day(s) ago - refreshing...

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

This is the most expensive it has ever been. Walk away.

£57 today · previous high £57 · all-time low £55

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 49 days · 49 data points (no recent data)

Historical
Generating forecast…
£56.56 £54.86 £55.23 £55.60 £55.97 £56.34 £56.72 26 April 2026 08 May 2026 20 May 2026 01 June 2026 13 June 2026

Price Distribution

Price distribution over 49 days • 3 price levels

Days at Price
Current Price
24 days 20 days · current 5 days · current 0 6 12 18 24 £55 £56 £57 Days at Price

Price Analysis

Most common price: £55 (24 days, 49.0%)

Price range: £55 - £57

Price levels: 3 different prices over 49 days

Description

Presents state-of-the-art regulatory cancer risk assessment models including a biologically based model for two-hit carcinogenesis and cell proliferation! This book comprehensively reviews the various roles of genetic toxicology in human cancer risk assessment conducted by United States and worldwide regulatory agencies-discussing hazard identification, dose-response relationships, exposure assessment, and current practices of risk characterization. Examines predictive values of mutagenicity tests, mechanisms of carcinogenesis, and conventional genotoxicity tests required by the International Conference on Harmonization and the Organization for Economic Cooperation and Development/Environmental Protection Agency guidelines! Comprised of contributions from prominent experts and risk assessors and including nearly 1200 references to facilitate further study, Genetic Toxicology and Cancer Risk Assessment reviews contemporary human cancer genetics as related to the mutagenic nature of carcinogenesis calculates acceptable exposure levels based on a carcinogenic threshold dose for nongenotoxic carcinogens reveals the rationale and methodology of quantitative estimation of human cancer risks using mathematical models discusses the threshold concept of carcinogenesis demonstrates how bacterial mutagenicity assays are the most reliable for predicting rodent carcinogens considers structural activity relationship (SAR) analysis of chemical carcinogenicity describes the emergence of the mouse lymphoma microwell and in vitro micronucleus assays illustrates the use of genetic biomarkers for dosimetry analysis and more! Linking human cancer genetics, mutagenicity assays, mechanisms of carcinogenesis, carcinogenic thresholds, molecular epidemiology, mathematical modeling, and quantitative cancer risk analysis, Genetic Toxicology and Cancer Risk Assessment is a must-have reference for toxicologists; oncologists; geneticists; biostatisticians; reproductive, developmental, cell, and molecular biologists; endocrinologists; biochemists; and upper-level undergraduate, graduate, and medical school students in these disciplines.

Product Specifications

Format
hardcover
Domain
Amazon UK
Release Date
31 August 2001
Listed Since
17 February 2007

Barcode

No barcode data available

Similar Products You Might Like

Thresholds of Genotoxic Carcinogens: From Mechanisms to Regulation
97% match

Thresholds of Genotoxic Carcinogens: From Mechanisms to Regulation

Academic Press

£79.67 30 Jun 2026
Molecular Carcinogenesis and the Molecular Biology of Human Cancer
96% match

Molecular Carcinogenesis and the Molecular Biology of Human Cancer

CRC Press

£235.00 10 Jun 2026
Mechanisms of Environmental Mutagenesis-Carcinogenesis (Mechanisms of Environmental Mutagenesis-carcinogenesis: Meeting Proceedings)
96% match

Mechanisms of Environmental Mutagenesis-Carcinogenesis (Mechanisms of Environmental Mutagenesis-carcinogenesis: Meeting Proceedings)

Springer

£34.44 27 Jun 2026
Carcinogenesis and Mutagenesis Testing: 4 (Contemporary Biomedicine, 4)
96% match

Carcinogenesis and Mutagenesis Testing: 4 (Contemporary Biomedicine, 4)

Humana

£84.27 22 Jul 2026
Genomics and Pharmacogenomics in Anticancer Drug Development and Clinical Response (Cancer Drug Discovery and Development)
96% match

Genomics and Pharmacogenomics in Anticancer Drug Development and Clinical Response (Cancer Drug Discovery and Development)

Humana

£16.79 17 Jun 2026
Molecular Biology of Human Cancers
96% match

Molecular Biology of Human Cancers

Springer

£96.11 16 Jun 2026
Molecular Biology of Human Cancers
96% match

Molecular Biology of Human Cancers

Springer

£73.10 16 Jun 2026
Cancer: Principles and Practice of Oncology Primer of Molecular Biology in Cancer
96% match

Cancer: Principles and Practice of Oncology Primer of Molecular Biology in Cancer

WOLTERS KLUWER HEALTH

£55.30 25 Jun 2026
The Molecular Basis of Human Cancer
96% match

The Molecular Basis of Human Cancer

Humana

£174.22 13 Jul 2026
Targeting the DNA Damage Response for Anti-Cancer Therapy (Cancer Drug Discovery and Development)
96% match

Targeting the DNA Damage Response for Anti-Cancer Therapy (Cancer Drug Discovery and Development)

Humana

£147.01 04 May 2026
Humana - Targeting the DNA Damage Response for Anti-Cancer Therapy
96% match

Humana - Targeting the DNA Damage Response for Anti-Cancer Therapy

Humana

£147.14 21 Jul 2026
Springer Molecular Basis of Human Cancer - NATO Science Series
96% match

Springer Molecular Basis of Human Cancer - NATO Science Series

Springer

£121.37 08 May 2026
p53 in the Clinics
96% match

p53 in the Clinics

Springer

£80.66 07 Jul 2026
Mutant p53 and MDM2 in Cancer: 85 (Subcellular Biochemistry, 85)
96% match

Mutant p53 and MDM2 in Cancer: 85 (Subcellular Biochemistry, 85)

Springer

£100.21 17 Jul 2026
Springer Mutant p53 and MDM2 in Cancer - Subcellular Biochemistry 85
96% match

Springer Mutant p53 and MDM2 in Cancer - Subcellular Biochemistry 85

Springer

£108.01 22 Jul 2026
The Molecular Basis of Cancer
96% match

The Molecular Basis of Cancer

Saunders

£129.00 18 Jun 2026
Cancer Susceptibility: Methods and Protocols: 653 (Methods in Molecular Biology, 653)
96% match

Cancer Susceptibility: Methods and Protocols: 653 (Methods in Molecular Biology, 653)

Humana

£104.18 12 Jun 2026
Precision Cancer Therapies, Targeting Oncogenic Drivers and Signaling Pathways in Lymphoid Malignancies: From Concept to Practice: 1 (Precision Cancer Therapies, Volume 1)
96% match

Precision Cancer Therapies, Targeting Oncogenic Drivers and Signaling Pathways in Lymphoid Malignancies: From Concept to Practice: 1 (Precision Cancer Therapies, Volume 1)

Wiley-Blackwell

£117.43 17 Jul 2026
Principles of Cancer Genetics
96% match

Principles of Cancer Genetics

Springer

£81.59 12 Jun 2026
Expression Profiling of Human Tumors: Diagnostic and Research Applications
96% match

Expression Profiling of Human Tumors: Diagnostic and Research Applications

Humana

£46.05 17 Jul 2026
The Paradoxical Situation in Carcinogenesis: Optimistic Mistake or Pessimistic Truth?
96% match

The Paradoxical Situation in Carcinogenesis: Optimistic Mistake or Pessimistic Truth?

Cambridge Scholars Publishing

£63.99 16 Jun 2026
Principles of Cancer Genetics
96% match

Principles of Cancer Genetics

Springer

£59.47 13 Jun 2026
Expression Profiling of Human Tumors: Diagnostic and Research Applications
96% match

Expression Profiling of Human Tumors: Diagnostic and Research Applications

Humana

£80.65 24 May 2026
Cancer Epigenetics for Precision Medicine: Methods and Protocols: 1856 (Methods in Molecular Biology, 1856)
96% match

Cancer Epigenetics for Precision Medicine: Methods and Protocols: 1856 (Methods in Molecular Biology, 1856)

Humana

£117.75 27 Jun 2026